Prevention of mild cognitive impairment, dementia and Alzheimer's disease with treatment of TNF-α inhibitor
Latest Information Update: 28 Aug 2020
At a glance
- Drugs Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Methotrexate (Primary)
- Indications Alzheimer's disease; Cognition disorders; Dementia
- Focus Therapeutic Use
- 28 Aug 2020 New trial record
- 31 Jul 2020 Results presented at the Alzheimer's Association International Conference 2020